Cell therapy manufacturing is uniquely vulnerable to contamination, variability, and operational burden because the product - ...
The detection of certain cardiac issues in a study of healthy volunteers led Aardvark to pause a Phase 3 trial only months ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results